221 related articles for article (PubMed ID: 9336418)
1. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
Kremer JM; Alarcón GS; Weinblatt ME; Kaymakcian MV; Macaluso M; Cannon GW; Palmer WR; Sundy JS; St Clair EW; Alexander RW; Smith GJ; Axiotis CA
Arthritis Rheum; 1997 Oct; 40(10):1829-37. PubMed ID: 9336418
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y
Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate pulmonary toxicity.
Cannon GW
Rheum Dis Clin North Am; 1997 Nov; 23(4):917-37. PubMed ID: 9361161
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.
Alarcón GS; Kremer JM; Macaluso M; Weinblatt ME; Cannon GW; Palmer WR; St Clair EW; Sundy JS; Alexander RW; Smith GJ; Axiotis CA
Ann Intern Med; 1997 Sep; 127(5):356-64. PubMed ID: 9273826
[TBL] [Abstract][Full Text] [Related]
6. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
7. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis.
Hilliquin P; Renoux M; Perrot S; Puéchal X; Menkès CJ
Br J Rheumatol; 1996 May; 35(5):441-5. PubMed ID: 8646434
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
10. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
11. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N
J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718
[TBL] [Abstract][Full Text] [Related]
12. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
13. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
14. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate update.
Kremer JM
Scand J Rheumatol; 1996; 25(6):341-4. PubMed ID: 8996467
[TBL] [Abstract][Full Text] [Related]
16. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
Marchesoni A; Battafarano N; Arreghini M; Panni B; Gallazzi M; Tosi S
Rheumatology (Oxford); 2003 Dec; 42(12):1545-9. PubMed ID: 12810924
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function in patients receiving long-term low-dose methotrexate.
Cottin V; Tébib J; Massonnet B; Souquet PJ; Bernard JP
Chest; 1996 Apr; 109(4):933-8. PubMed ID: 8635373
[TBL] [Abstract][Full Text] [Related]
18. Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study.
Pamuk ON; Kisacik B; Pamuk GE; Onat AM; Sayarlioglu M; Donmez S; Pehlivan Y; Keystone EC
Rheumatol Int; 2013 Oct; 33(10):2631-5. PubMed ID: 23743624
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW
Arthritis Rheum; 2007 May; 56(5):1424-32. PubMed ID: 17469099
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
